GINA UZENDU: Open Payments
NPI 1740481142 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$747 in 6 payments from 6 companies in 2025. Trend: 2023 $1,804 · 2024 $1,578 · 2025 $747
Food & beverage: $747
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 1 | $162 |
| Amgen Inc. | 1 | $129 |
| Axsome Therapeutics, Inc. | 1 | $125 |
| AstraZeneca Pharmaceuticals LP | 1 | $122 |
| Teva Pharmaceuticals USA, Inc. | 1 | $109 |
| Corcept Therapeutics | 1 | $100 |
Products named: FREESTYLE LIBRE 3, Auvelity, FASENRA, UZEDY, Korlym.
Industry payments across MO — which companies pay providers there.
